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ABSTRACT
Inflammatory bowel disease (IBD) has begun to emerge in Indonesia. The disease is further classified 
into two types, ulcerative colitis (UC) and Crohn's disease (CD). Diagnosis of IBD is initiated from symptom 
findings such as diarrhea, abdominal pain, bleeding diarrhea, and weight loss, and supported by physical 
examination and additional tests. The options for additional examinations of IBD are mainly endoscopy 
(esophagogastroduodenoscopy, colonoscopy, and also intestinal endoscopy), imaging techniques, and laboratory 
examinations either from blood or feces. The application of these modalities should be prompted by sufficient 
clinical suspicion to promote their efficiency as well as prevent underdiagnosis or overdiagnosis. In primary 
health care settings, patients with IBD are expected to be recognized for therapy or to use appropriate referral 
system to warrant a proper treatment. 
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ABSTRAK
Inflammatory bowel disease (IBD) mulai banyak ditemukan di Indonesia. Penyakit ini terbagi atas dua jenis 
yaitu kolitis ulseratif (KU) dan penyakit Crohn (PC). Diagnosis IBD dimulai dari gejala yang ditemukan seperti 
diare, nyeri perut, buang air besar berdarah dan penurunan berat badan, serta didukung oleh pemeriksaan fisik 
dan pemeriksaan penunjang. Pilihan pemeriksaan penunjang untuk IBD secara garis besar adalah endoskopi 
(esofagogastroduodenoskopi, kolonoskopi maupun endoskopi usus halus), pencitraan, dan pemeriksaan 
laboratorium, baik dari darah atau feses. Penggunaan berbagai modalitas ini harus didahului adanya kecurigaan 
yang cukup secara klinis agar tepat guna, mencegah under- atau overdiagnosed. Pada tingkat layanan primer, 
pasien IBD juga diharapkan dapat ditemukan untuk diterapi atau menggunakan sistem rujukan yang tepat agar 
ditatalaksana dengan baik. 
Kata kunci: inflammatory bowel disease, diagnosis terkini, kolitis ulseratif, penyakit Crohn
INTRODUCTION
A digestive tract abnormality, inflammatory bowel 
disease (IBD), is categorized as inflammatory disease 
with still unknown cause. IBD is divided into 2 main 
disease entities, such as ulcerative colitis (UC) and 
Crohn's disease (CD). If it is still undetermined between 
the two, it can be called undetermined colitis.1 The peak 
age of patients with IBD is quite young (25-30 years 
old) and there is no significant difference between 
male and female.2 Most IBD patients are 15-30 years 
old, although it may happen in all ages. UC is slightly 
fewer in male, while CD is more frequent in female.3 
Initially, incidence tends to increase in developed 
countries with tendency in white race, high social 
economy, non-smoker, oral contraception recipient 
and low fiber diet. But the incidence in this century 
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tends to persist in developed countries and increases 
in developing countries.1 From Centers for Disease 
Control and Prevention (CDC) data, it is known that 
the incidence rate of UC varies from 0.5–24.5/100,000 
persons, while CD from 0.1–16/100,000 persons. It is 
predicted that currently as much as 1.4 million people 
in United States suffer from this disease.3 
Data in Cipto Mangunkusumo Hospital from 
total colonoscopies in 2002, as much as 5.2% were 
UC cases, while 5.2% were CD.1 Meanwhile from 
colonoscopy results in 2001-2006, it was found that 
total colonoscopies were 1541 times and IBD was 
diagnosed as much as 8.3%, with 5.4% UC and 2.9% 
CD.1 In several other hospitals, it was also reported that 
more UC was found as compared to CD.1,2 Currently, 
there has been no quite satisfactory epidemiology 
data, only endoscopy database from each hospital. 
Based on symptoms complained by IBD patients, 
the most common was bleeding chronic diarrhea and 
stomachache, followed by chronic diarrhea, and the 
least was hematoschezia.1
Diagnosis of IBD supposedly can be confirmed 
from primary health care, however without suffient 
directed suspicion, even in tertiary health care centre 
this disease may be missed. In contrast, not all chronic 
diarrhea or bleeding diarrhea is caused by intestinal 
inflammation, therefore over diagnosing also needs 
to be hindered.4
CONFIRMING DIAGNOSIS
There is no definite diagnostic test for IBD. 
Diagnosis is expected to be made clinically, particularly 
in health care centre which is not tertiary. Diagnosis 
is made based on the symptoms and physical 
examination, strengthened by endoscopy, radiology, 
laboratory and histopathology findings. In both types 
of IBD, clinical presentation varies. The differential 
diagnosis is gastrointestinal tuberculosis. Through 
radiology and endoscopy, they are difficult to be 
differed from each other and may have similar 
predilection anatomy. Meanwhile, the degree of disease 
activity may be evaluated using disease activity index 
which is different for CD and UC.1,2 
Ulcerative colitis according to the definition is 
an inflammation condition which is limited to the 
colon, therefore it is mainly divided anatomically, 
particularly proxitis (limited to the rectum), left side 
colitis (sigmoid colon with or without descending 
colon involvement), or pancolitis. Some patients 
also experience inflammation of the ileum, known 
as ‘backwash ileitis’ condition. This last condition 
frequently causes difficulty to differentiate UC and 
ileocolitis in CD.5
Figure 1. Illustration of anatomical involvement in ulcerative 
colitis5
Clinical Manifestations
There are four main symptoms frequently complained 
by IBD patients, which are diarrhea, stomachache, 
bloody stool and decreased body weight. Meanwhile a 
review by Jellema et al found that these four symptoms 
were neither sensitive nor specific to confirm the 
diagnosis of IBD.6 Several diagnostic criteria based 
on symptoms (symptom-based criteria) have been 
developed, such as Manning and Kruis criteria. If 
group of one's complaints is inserted to this criteria, the 
sensitivity and specificity to diagnose is better, with the 
number of more than 65% for both in several studies.6
Confirming Diagnosis in Primary Health Care Centre
In Indonesia primary health care centre plays very 
important role, considering the spread of population 
in variable geographical terrain, while the access to 
reach tertiary health care centre or type A hospital may 
be difficult. IBD complaints are quite varied, ranging 
from mild symptom, such as localized stomachache, up 
to quite a lot of digestive tract bleeding, which makes 
it necessary to perform simple diagnostic method that 
could be performed as soon as possible in primary 
health care centre. In a review by Jellema et al, three 
groups of main diagnostic steps which has been studied 
in primary health care centre or similar were reviewed, 
particularly those based on symptoms and signs, blood 
and fecal test, and abdominal ultrasonography (USG).6 
Jellema et al in their systematic review found that 
between those three diagnostic modalities, only faecal 
calprotectin test and USG had quite good results, but 
both were still rare to be performed in primary health 
care centre level.6 In Indonesia, a national consensus 
has been arranged, including algorithm of diagnostic 
work-up and management in variable health care level, 
starting from primary to tertiary.1
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Endoscopy
To diagnose IBD, one of the most frequently used 
procedures is endoscopy. Either colonoscopy or even 
esophagogastroduodenoscopy (EGD) is needed to 
visualize digestive tract mucosa as much as possible. 
Normal colon mucosa has clear vascular pattern and 
pale glossy colour. The occurrence of inflammation in 
IBD changes the appearance partially or even entire 
colon mucosa.1,2
Table 1. Endoscopic appearances in inflammatory bowel 
disease1,2
Endoscopic appearance Ulcerative collitis
Chron’s 
disease
Continuous characteristic +++ +
Presence of skip area 0 +++
Rectum involvement +++ +
Easily bleeding lesion +++ +
Cobblestone appearance/pseudopolyps + +++
Ulcer characteristics
Found in inflamed mucosa +++ +
Ileal involvement 0 ++++
Discrete ulcer lesion + ++++
Ulcer shape +++
Diameter > 1 cm + +++
Depth, linear shape + +++
Aphtoid 0 ++++
0: not found; +: mild/less found; ++ : much found; +++: abundantly found
about the use of small intestine endoscopy for 
diagnosis of IBD. There are several types of small 
intestine endoscopy, which are: small-bowel capsule 
endoscopy (SBCE), push enteroscopy, double-balloon 
enteroscopy (DBE), single-balloon enteroscopy (SBE), 
intraoperative enteroscopy (IOE), and the latest 
technique is spiral enteroscopy.7
Small-bowel Capsule Endoscopy
Small-bowel capsule endoscopy (SBCE) uses a 
capsule containing camera which directly transmits 
pictures to computer which has been installed with 
specific software as long as the battery life, which is 
8-10 hours, without manual probe. The weaknesses 
are that particular manuever cannot be performed if an 
area need to be examined more detailed and inability to 
perform biopsy at the same time. The contraindication 
occurs when it is suspected that an obstruction might 
be present although partial, because camera impaction 
inside the body might occur.7 
Push Enteroscopy
This enteroscopy uses a long flexible endoscopic 
tool (paediatric colonoscope, or enteroscope), which 
end is continued until it passes Traits ligament. 
However, this technique can only visualize until 
proximal jejunum.7
Double-balloon Enteroscopy
Double-balloon enteroscopy (DBE) technique is 
included as device assisted endoscopy (DAE), which 
is endoscopy using additional auxiliary tool in the 
form of balloon and overtube. In DBE, overtube 
and two balloons at both ends are being used. So 
that, endoscope with overtube may go further to 
distal/proximal of intestine, inflation and deflation 
of the balloon is performed alternately in those two 
baloons, simultaneously with endoscope insertion and 
retraction.7 
Manes et al in their study regarding the use of 
DBE in CD in high prevalence of CD in tertiary 
health care centre, found that the ability of DBE to 
diagnose PC was only in 50% patients.8 Although, 
this examination is still more sensitive compared to 
radiological examination. Radiology can only detect 
larger lesion or there has been complication, such as 
stricture. The advantage of DBE in this case is that if 
found, visualization can be more focused and biopsy 
can be performed. The success of DBE with oral or anal 
insertion route, needs good technical ability, and needs 
Several abnormalities which may be found in UC: 
1) Vascular pattern disappears, due to mucosal edema 
and erythema. Petechiae, exudate, and contact bleeding 
may appear; 2) In more severe cases, macroulceration, 
significant bleeding or exudation may occur; 3) 
Continuous involvement of colon; pseudopolyp may be 
present due to past inflammatory process. Meanwhile in 
CD, abnormalities which may be found: 1) Focal ulcer 
appearance, beside mucosa which looks to be normal; 
2) Partial mucosa showed polypoid appearance which 
forms the cobblestone appearance; 3) Involvement of 
partial mucosa (with skip areas) is typical appearance, 
which differs it with UC; 4) Pseudopolyp is mucosal 
membrane mass which is hypertrophic, may appear in 
CD, as well as UC.2
Definitely, UC showed signature involvement, 
which is from distal, rectum, and continuously involve 
the proximal area, broad or limited. While in CD 
involved mucosa may be only one area. Both cause the 
need of small intestine mucosa visualization which is 
generally difficult to reach through endoscopy.2 
SMALL INTESTINE ENDOSCOPY AS DIAGNOSTIC 
TOOL OF INFLAMMATORY BOWEL DISEASE
Guidelines from European Crohn’s and Colitis 
Organisation (ECCO) and Organisation Mondiale 
d’Endoscopie Digestive (OMED) are specifically 
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information from previous examinations, particularly 
about location and possibility of a lesion to be present.8 
Single-balloon Enteroscopy
Using similar principle to DBE, in single-balloon 
enteroscopy (SBE) only endoscope, overtube and 
without balloon at the distal end are being used. This 
technique is considered more simple compared to DBE.7 
Intraoperative Enteroscopy
In intraoperative enteroscopy (IOE), enteroscopy 
is performed intraoperative by using scope inserted 
through mouth or even through enterotomy. Progression 
of enteroscope is assisted manually from outer part of 
small intestine during surgery.7 
Spiral Enteroscopy
This technique uses enteroscope with overtube with 
spiral end and can rotate by itself. Further studies are 
still needed about its usage in the diagnosis of IBD.7
HISTOPATHOLOGY
Pathological appearance in UC is important to 
differentiate it with infective colitis. Pathological 
findings include crypt abcess, gland atrophy, loss of 
mucin in goblet cells, crypt distortion, mononuclear 
and polymorphonuclear (PMN) cells infiltration in 
lamina propria. This findings differentiate UC with 
other diseases.9 While in CD, there will be tuberculoid 
granuloma, macrophage and lymphocytes infiltration 
to lamina propria, also deep ulcer.1,2
LABORATORY EXAMINATION
Some of IBD markers which are evaluated are in 
the form of antibodies, while the others are in the form 
of acute phase protein, or other molecule protein found 
in the serum or faeces of IBD patients. The presence 
of antibody which is used as an IBD marker is thought 
to be due to the lost of immune system tolerance to 
antigen which is normally found in the intestinal lumen. 
Probably it is also caused by the increase of intestinal 
wall permeability.10 Some autoantibodies are expected 
to be used in differentiating between CD and UC, but 
longitudinal studies are still needed to know their 
predictive values.10
ASCA and pANCA
Two antibodies which have been quite widely studied 
are anti Saccharomyces cerevisiae antibody (ASCA) 
and atypical perinuclear anti-neutrophil cytoplasmic 
antibody (pANCA). Although individually the sensitivity 
or specificity is quite small, but the combination use of 
both is beneficial to confirm the diagnosis of IBD, even 
to differentiate between UC and CD.10 
From a study followed by 582 IBD patients, it was 
reported that the sensitivity was 40-60% if used alone 
or in combination, and specificity was > 90% to detect 
IBD compared to control. Meanwhile from the serology 
used to categorize undetermined colitis into UC or CD, 
it was found that 32% (31/97) patients which succeed 
to be categorized further, with the outcome of ASCA-
positive and pANCA-negative in association with CD, 
as much as 80% confirmed. While ASCA-negative 
and pANCA-positive associated UC, as much as 63% 
matched. ASCA is also found positive in celiac disease, 
therefore ASCA is possibly a non-specific immune 
response in small intestine abnormality. Additionally, it 
is also reported that ASCA has ever increased in cystic 
fibrosis, and intestinal tuberculosis (TB).4
Larger number was found in a study performed by 
Nisihara et al.10. Sensitivity and specificity of pANCA 
to diagnose UC were 51% and 100% respectively, 
while the sensitivity and specificity of ASCA for CD 
were 62% and 93%, respectively. If the use of both 
was combined to differentiate between UC and CD, 
the specificity rate found was larger, compared to only 
one of the tests. Combination of pANCA positive and 
ASCA negative (pANCA+/ASCA -) had specificity 
rate to diagnose as much as 95% for UC. In contrast, 
combination of pANCA negative and ASCA positive 
(pANCA-/ASCA+) had diagnostic specificity of 90% 
for CD. Nisihara et al found the high association of 
ASCA IgG compared to the tendency of CD in the ileal 
location, and younger age onsite. In analysis of pANCA, 
positive value was closely associated with the presence 
of UC in the form of left-sided colitis or pancolitis.10
Anti-OmpC Antibody 
OmpC is porin in the outer membrane of Eschericia 
coli which is immunoreactive to pANCA monoclonal 
antibody. It is reported to be found positive in 46% 
from 303 adults with CD, studies on other antibodies 
are still ongoing.11
C-reactive Protein
Acute phase protein increases in IBD, and is 
generally higher in CD compared to UC. The C-reactive 
protein (CRP) level is reported to be associated with 
the activity of CD, and may predict CD, but is still 
controversial.9
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Bacterial Profile
The role of intestinal microbes in the etiology of 
IBD is thought to be based on the principle of presence 
of intestinal mucosa immune activation which is 
inappropriate to the intestinal microbe.12 Microbes 
profile in different types of IBD phenotypes is also 
found to be different. Microbes composition in patients 
with CD is different compared to healthy individuals 
or even those with UC. While in UC patients, there 
is not much difference with healthy individuals. 
Specific changes which have been found in ileal type 
CD are decrease of specific types of bacteria, such as: 
Faecalibacterium and Roseburia, also the increase 
of Enterobacteriaceae and Ruminococcus gnavus.12 
This is proved by Willing et al through their study, 
microbes profile using pyrotag, towards 40 twin pairs 
who suffered IBD, either concordant or discordant.12
Procalcitonin
Procalcitonin (PCT) has been widely studied as a 
good infection marker, particularly in post surgery and 
sepsis. Joo et al evaluated the role of PCT in bacterial 
gastroenteritis and IBD, two intestinal inflammation 
conditions which are frequently found and difficult to 
differentiate. The study proved PCT with the cut off 
of 0,5 ng/mL has 40% sensitivity and 92% specificity 
for bacterial gastroenteritis (GE). While in IBD 
patients, PCT was not increased either in active or 
inactive phase of the disease. This study also found 
that other inflammatory markers, such as erythrocyte 
sedimentation rate (ESR) and CRP were found to be 
increased in active IBD, while PCT was still below 
the cut off value.13
MANNAN-BINDING LECTIN 
Mannan-binding lectin (MBL) is a binding molecule 
which may activate complement through lectin pathway. 
This is an activated non-specific immune response to 
microorganisms. Therefore, it is predicted that the level 
is increased in IBD. A study by Hoffman et al, in 98 CD 
patients, 83 UC, 189 healthy controls, and 82 rheumatic 
patients as controls, there was no difference found in 
the MBL level and MBL genotype difference in those 
groups. Thus, MBS until recently is proved to be not 
beneficial in diagnosing IBD.14
S100 Protein Group
S100 protein group has been widely known to 
play role in many diseases, either inflammation 
or malignancy. It is named S100 because all these 
proteins dissolve in 100% ammonium sulphate. Those 
associated with digestive tract inflammation, include 
calprotein, and calgranulin. Sample was collected 
from blood, intestinal biopsy, or faeces. The level of 
calprotein and calgranulin increased in IBD, and can 
differentiate between IBD, healthy subjects, or IBS. 
Unfortunately the level also increased in bacterial 
gastroenteritis. In a meta-analysis cited by Manolakis 
et al with 5.983 patients, it was reported that the 
sensitivity and specificity of calprotectin faeces for 
IBD diagnosis was 95 and 91%, respectively.15
Fecal Calprotectin
Fecal calprotectin is the most protein found in the 
cytosol of inflammed cell. The calprotectin level in faeces 
is predicted to be able to detect the possibility of someone 
to suffer from IBD. Hence, calprotectin is expected to 
be a screening tool for IBD, and prevent unnecessary 
endoscopy procedure in patients with slight possibility of 
IBD. From a meta-analysis by van Rheenen et al, which 
included 13 studies in adults and children, found that 
the sensitivity rate of 93% and specificity rate of 96% 
in adults. In this study, faecal calprotein screening in 
patients suspected with IBD, could decrease the number 
of endoscopy need as much as 67%.16
Fecal Lactoferin
Marker from feces is predicted to have higher 
specificity for IBD because the level is not increased 
in process occuring outside the digestive tract. 
Lactoferin is a glicoprotein found in secondary 
granule in polymorphonuclear (PMN). If there is an 
inflammation process in the intestinal mucosa, PMN 
will infiltrate mucosa and this secondary granule is 
released, therefore the level of lactoferin in the faeces 
will increase. The level increases before the increase 
of CRP and ESR, and examination through faeces 
decreases the possibility to be influenced by other 
factors, such as other systemic markers.17
The level of fecal lactoferin increases in IBD, 
compared to healthy controls and IBS patients. But the 
level is also increased in other gastroenteritis infection, 
although not as much as IBD. From many studies, 
it was concluded that the sensitivity and specificity 
was as much as 80% and 82%, as a combination of 
UC and CD. With subanalysis, it was found that the 
sensitivity and specificity of UC were 74% and 82%, 
and for CD the sensitivity and specificity were 75% and 
77%. The association of faecal lactoferin with disease 
activity either clinically (using activity index) or even 
histopathology and endoscopy were quite strong. 
Hence, it is expected that detecting the increase may 
visualize the activity and prognosis of IBD.17
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Chromogranin A
Chromogranin A (CgA) is an acid glicoprotein, 
and has been proved to be a sensitive marker for 
neuroendocrine tumor, including gastrointestinal 
carcinoid. However, the level is also found to be 
increased in kidney failure, atrophy gastritis, PPI 
therapy, or in the presence of neuroendocrine 
involvement in a condition, such as: rheumatoid 
arthritis, other malignancy, and chronic obstructive 
pulmonary disease (COPD). Based on several new 
studies, increase of CgA level was found in IBD, 
simultaneous with the presence of finding of increased 
risk of carcinoid tumor in IBD. Although this does not 
made CgA as one of the IBD diagnostic modalities, 
CgA may be examined as a marker if there is suspicion 
of carcinoid or neuroendocrine tumor in patients 
diagnosed with IBD.18
A study performed by Sciola et al evaluated the 
level of plasma CgA in IBD patients and control. It was 
found that CgA level was significantly higher in IBD, 
with significant cut-off value of 100 U/L, for carcinoid 
tumor, with or without the presence of IBD.18 
IMAGING
Abdominal Ultrasonography
Ultrasonography (USG) has been widely studied 
as a diagnostic tool for IBD which is noninvasive and 
quite easy to perform, the availability of the device 
has reached primary health care level. Several studies 
included the cut-off value of the involved colon wall 
thickness, with the combination of symptoms and 
other signs from IBD. The sensitivity reaches 73% 
(95% CI = 65–80%) and specificity reaches 95% (95% 
CI = 91–97%).6 
Magnetic Resonance Imaging 
Application of imaging techniques in diagnosis 
of IBD was initially targeted to invent a more 
comfortable and non-invasive diagnistic tool. A study 
was conducted to design a scoring system based on 
magnetic resonance imaging (MRI) which consisted 
of intestinal wall thickness, contrast enhancement 
in intestinal wall, and the presence of regional 
lymph nodes. Using this system, more than 90% of 
patients with any intestinal changes were diagnosed 
appropriately and have been categorized into mild, 
moderate, or severe inflammation.19 
Nevertheless, some studies also found the limitation 
of MRI in IBD detection, which was its inaccuracy in 
detecting mild intestinal inflammation, as compared 
to endoscopic capsule. On the other hand, endoscopic 
examinations would not be able to determine the 
depth of intestinal wall inflammation or the presence 
of transmural abnormalities such as fistula. Hence, 
endoscopic capsule and MRI are considered to be 
complemental to each other. By performing MRI in 
advance, in case of an intestinal stricture, the use of 
endoscopic capsule would not be necessary.19, 20 
Magnetic Resonance Imaging: Oral Contrast
Magnetic resonance imaging using orally ingested 
contrast medium was supposed to detect lesions on 
intestinal mucosal walls. This sort of imaging used an 
orally ingested contrast medium, followed by serial MRI 
examinations, in given sections, in accordance to the 
appropriate time the contrast needed to reach certain parts 
of intestines. Examination is complete once contrast-filled 
colon distension is sufficient and the images have been 
taken until the contrast reached cecum.21
Cronin et al reported their study and found 16 of 
53 patients undergoing oral contrast MRI had some 
abnormalities. All of them had thickened intestinal 
walls, and the second most common finding was 
lumen constriction. The best imaging and intestinal 
distensions were acquired from the sections of cecum 
and ascending colon. The most common lesions were 
found in cecum and transverse colon. Compared to 
endoscopy, oral contrast MRI had 80% sensitivity and 
100% specificity.21
Double Contrast Magnetic Resonance Imaging 
(DC-MRI)
The term 'double contrast' in double contrast 
magnetic resonance imaging (DC-MRI) procedure 
refers to the use of two contrast media simultaneously, 
negative superparamagnetic oral contrast and positive 
paramagnetic intravenous contrast. This technique will 
eventually result in black-white image, or two contrast 
effect which defines a solid difference between intestinal 
and luminal walls, especially in an inflammed area in 
T1-T2 weighted image. Specifically, this method will 
enhance the contrast on the intrinsic intestinal wall on 
T2 weighted image; hence, any signs of intestinal wall 
edema will be visualized clearly. In an active Crohn's 
disease, image of intestinal wall edema will be enhanced 
simultaneously with intravenous gadolinium contrast 
and on mural signal of T2 image, as compared to the dark 
luminal effect. Another name of this DC-MRI is negative 
MR-enterography due to the dark luminal image on both 
T1 and T2 produced by oral superparamagnetic contrast 
medium. T2 signal enhancement may also be found in 
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adjacent mesenteric tissues, which suggests serositis 
and/or inflammation and edema of the mesenterium. 
These three findings have been associated as the marker 
of CD activity in other studies.22 
UC images may also be identified using DC-MRI. 
Thickened wall was continuously found at the level of 
rectum, sigmoid colon, and sometimes along the colon 
to cecum in T1 and T2 images. Wall enhancement 
and local hypervascularities could be visible in active 
colitis, although it might not be as clear as in colitis 
caused by PC. Besides, pathological findings may 
reveal the loss of haustrae and luminal stricture in 
coronal T2 images.22 
Optimization of tissue lesion imaging depends on 
proper sequences, negative intestinal contrast medium, 
adipose suppression, and type of intravenous contrast 
medium being used. These are vital in identification of 
IBD lesions in colon and intestines. Besides, primary 
markers of mural and transmural inflammation in CD 
may be found in T1-T2 weighted image to assess the 
disease activity.22 
CONCLUSION
IBD is found quite often in tertiary health services. 
Based on the symptoms suffered by patients with 
IBD, the most common ones are chronic and bleeding 
diarrhea, abdominal pain, and chronic diarrhea. Many 
diagnostic modalities are available, while the most 
common and mainly used is endoscopy. Endoscopy 
followed by histopathologic examination is expected to 
help distinguish it from other differential diagnosis such 
as bacterial infective colitis or intestinal tuberculosis
Several examinations as being discussed in this 
review are not yet available in Indonesia, but they may 
expand the knowledge on novel diagnostic modalities 
in IBD. Further studies are needed to determine their 
specificities and sensitivities in Asian population, 
especially Indonesians. These numerous modalities 
are anticipated to be diagnostic options for IBD in 
every level of healthcare services, from primary to 
tertiary. Financial and geographic limitations make 
primary health services essential in first recognition 
of IBD. A thorough literature review focusing on 
the effectiveness of diagnostic modalities for IBD in 
primary health services is needed.
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